Goldman Sachs Upgrades Monster Beverage (MNST) to Conviction Buy; Sees "Monster" Growth
Get Alerts MNST Hot Sheet
Price: $47.49 --0%
Rating Summary:
20 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 23
Rating Summary:
20 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 23
Join SI Premium – FREE
Goldman Sachs upgraded Monster Beverage (NASDAQ: MNST) from Neutral to Conviction Buy with a price target of $124, suggesting 28% upside.
The firm said Monster offers the best growth stories in consumer staples, with 20%+ growth, due to strong brand momentum. Goldman also said they see tea/energy drink brand "Rehab" adding another leg of already strong sales growth.
Goldman raised EPS estimates and are now 6%-7% above consensus for 2012 and 2013.
For an analyst ratings summary and ratings history on Monster Beverage click here. For more ratings news on Monster Beverage click here.
Shares of Monster Beverage closed at $96.99 yesterday.
The firm said Monster offers the best growth stories in consumer staples, with 20%+ growth, due to strong brand momentum. Goldman also said they see tea/energy drink brand "Rehab" adding another leg of already strong sales growth.
Goldman raised EPS estimates and are now 6%-7% above consensus for 2012 and 2013.
For an analyst ratings summary and ratings history on Monster Beverage click here. For more ratings news on Monster Beverage click here.
Shares of Monster Beverage closed at $96.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Walmart (WMT) to Buy
- NetEase.com (NTES) PT Raised to $168 at Goldman Sachs
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share